PLASMABLASTIC LYMPHOMA
Clinical trials for PLASMABLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMABLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for PLASMABLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can gene-modified stem cells outsmart HIV and beat lymphoma?
Disease control OngoingThis early-phase study tests a gene therapy for people with HIV who also have lymphoma that didn't respond to treatment or came back. Doctors take the patient's own stem cells, add special anti-HIV genes in the lab, and give them back after a stem cell transplant. The goal is to …
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New combo therapy aims to boost immune attack on tough lymphomas
Disease control OngoingThis phase 2 trial tests whether adding varlilumab to nivolumab helps people with aggressive B-cell lymphomas that have returned or not responded to standard therapy. About 54 participants will receive either nivolumab alone or nivolumab plus varlilumab. The goal is to see if the…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:40 UTC